Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Alzheimer's Disease: A Journey from Amyloid Peptides and Oxidative Stress, to Biomarker Technologies and Disease Prevention Strategies-Gains from AIBL and DIAN Cohort Studies.
Martins RN, Villemagne V, Sohrabi HR, Chatterjee P, Shah TM, Verdile G, Fraser P, Taddei K, Gupta VB, Rainey-Smith SR, Hone E, Pedrini S, Lim WL, Martins I, Frost S, Gupta S, O'Bryant S, Rembach A, Ames D, Ellis K, Fuller SJ, Brown B, Gardener SL, Fernando B, Bharadwaj P, Burnham S, Laws SM, Barron AM, Goozee K, Wahjoepramono EJ, Asih PR, Doecke JD, Salvado O, Bush AI, Rowe CC, Gandy SE, Masters CL. Martins RN, et al. Among authors: wahjoepramono ej. J Alzheimers Dis. 2018;62(3):965-992. doi: 10.3233/JAD-171145. J Alzheimers Dis. 2018. PMID: 29562546 Free PMC article. Review.
The Effects of Testosterone Supplementation on Cognitive Functioning in Older Men.
Wahjoepramono EJ, Asih PR, Aniwiyanti V, Taddei K, Dhaliwal SS, Fuller SJ, Foster J, Carruthers M, Verdile G, Sohrabi HR, Martins RN. Wahjoepramono EJ, et al. CNS Neurol Disord Drug Targets. 2016;15(3):337-43. doi: 10.2174/1871527315666151110125704. CNS Neurol Disord Drug Targets. 2016. PMID: 26553159 Free PMC article. Clinical Trial.
Testosterone replacement therapy in older male subjective memory complainers: double-blind randomized crossover placebo-controlled clinical trial of physiological assessment and safety.
Asih PR, Wahjoepramono EJ, Aniwiyanti V, Wijaya LK, de Ruyck K, Taddei K, Fuller SJ, Sohrabi H, Dhaliwal SS, Verdile G, Carruthers M, Martins RN. Asih PR, et al. Among authors: wahjoepramono ej. CNS Neurol Disord Drug Targets. 2015;14(5):576-86. doi: 10.2174/1871527314666150429112112. CNS Neurol Disord Drug Targets. 2015. PMID: 25921747 Clinical Trial.
16 results